Boehringer Ingelheim commits to expand access to NCD healthcare for 50 million people
Boehringer Ingelheim has committed Ksh. 32 billion to investing in collaborations to combat infectious diseases in humans and animals.
Stay updated with breaking news from Kuza Afya. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Boehringer Ingelheim has committed Ksh. 32 billion to investing in collaborations to combat infectious diseases in humans and animals.
Boehringer Ingelheim recognized for its efforts to enhance access to medicine Shares Boehringer Ingelheim has been ranked among the top 20 largest pharmaceutical companies globally for the second time. The company ranked top for its ongoing effort to overcoming barriers to access to healthcare, especially for vulnerable groups and communities in developing countries. The biopharmaceutical company was ranked at number 12 amongst 20 of the largest pharmaceutical companies. This is two positions higher from last year in the bi-annual global Access-to-Medicine Index. The Access-To-Medicine rankin...